510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

Emit 2000 Quinidine Assay, Model OSR4Q229

K011605510(k) SpecialCleared Jun 12, 200119-day reviewClass II21 CFR 862.3320Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Syva Co., Dade Behring, Inc. · LBZ Enzyme Immunoassay, Quinidine

Cleared on Jun 12, 2001 after a 19-day review. The FDA summary names its predicate without a number. It has been recalled once.

Decided
Jun 12, 2001
Review
19 days
Class
Class II
Product code
LBZ
Recalls
1
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K011605Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LBZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Emit® 2000 Quinidine Assay
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 13, 2026Class IIZ-2976-2026Unknown/Undetermined by firmDue to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential…

No ancestor or descendant has a Class I recall.

How does its category compare?

All LBZ devices

LBZ Enzyme Immunoassay, Quinidine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LBZ

FDA has decided no LBZ device since 2007.

Median 510(k) review, days · LBZ

Too few LBZ 510(k)s in any year since 2007 to give a median.

Recalls per year · LBZ

2so far in 2026, the most since 2007

2026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LBZ

3in 2007

2007: 3
2007high 3 (2007) · low 0 (2008)2025

MAUDE reports naming product code LBZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—2—

What is it indicated for?

The Emit® 2000 Quinidine Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of quinidine in human serum or plasma. Measurements obtained from this device are used in the diagnosis and treatment of quinidine overdose or in monitoring levels of quinidine to ensure appropriate therapy. These reagents are packaged specifically for use on a variety of OLYMPUS® analyzers.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K011605: Emit 2000 Quinidine Assay, Model OSR4Q229.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K011605

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Page last updated Nov 3, 2026